Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000709512 | SCV000839336 | uncertain significance | Hereditary breast ovarian cancer syndrome | 2018-07-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002388351 | SCV002671844 | uncertain significance | Hereditary cancer-predisposing syndrome | 2020-11-06 | criteria provided, single submitter | clinical testing | The p.D254Y variant (also known as c.760G>T), located in coding exon 5 of the RAD51C gene, results from a G to T substitution at nucleotide position 760. The aspartic acid at codon 254 is replaced by tyrosine, an amino acid with highly dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |